Skip to content

Clinical trials

Phase 4 Atrial Fibrillation trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 4 Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20034
20061
20071
20082
20092
20102
20111
20141
20151
20181
20191
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting3
Unknown status3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Hopital Lariboisière2
MEDA Pharma GmbH & Co. KG2
Sanofi2
Atrial Fibrillation Network1
Biosense Webster, Inc.1
Boehringer Ingelheim1
Centre Hospitalier de PAU1
Dr Ange FERRACCI1
GCS Ramsay Santé pour l'Enseignement et la Recherche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation22
Stroke4
Ischemic Stroke2
Pulmonary Embolism2
Venous Thrombosis2
Acute Coronary Syndrome1
Antiphospholipid Syndrome1
Arrhythmias, Cardiac1
Atrial Flutter1
Cerebral Infarction1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.